AstraZeneca PLC (LON:AZN)
London
· Delayed Price · Currency is GBP · Price in GBX 14,318
+256 (1.82%)
Jun 26, 2026, 5:15 PM GMT
AstraZeneca Employees
AstraZeneca had 96,100 employees as of December 31, 2025. The number of employees increased by 1,800 or 1.91% compared to the previous year.
Employees
96,100
Change (1Y)
1,800
Growth (1Y)
1.91%
Revenue / Employee
476.28K GBP
Profits / Employee
81.87K GBP
Market Cap
222.07B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| GSK plc | 66,841 |
| Haleon | 24,535 |
| Smith & Nephew | 16,988 |
| Convatec Group | 10,910 |
| Hikma Pharmaceuticals | 9,400 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,796 |
| Oxford Nanopore Technologies | 1,316 |
AstraZeneca News
- 1 day ago - AstraZeneca (AZN) Receives EU Approval Recommendation for Breast Cancer Treatment - GuruFocus
- 1 day ago - AstraZeneca reports Datroway recommended for approval in EU by CHMP - TheFly
- 1 day ago - Daiichi Sankyo: Datroway Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy - Finanz Nachrichten
- 3 days ago - For decades, the only first treatment for one of the deadliest breast cancers was standard chemotherapy. Now there are two newly approved drugs. - WSJ
- 3 days ago - Top FTSE Shares for Beginners to Buy in 2026: AZN, REL and RR. - ABC Money
- 3 days ago - AstraZeneca and YMCA of the USA Announce Landmark Partnership Aimed to Address Gaps in Cancer Care - Business Wire
- 6 days ago - AIM Advances Phase 2 DURIPANC Study In Pancreatic Cancer; Expects Topline Data In Q1,2027 - Nasdaq
- 8 days ago - The U.S. has launched a trade investigation into a German plan to cut spending on pharmaceuticals, a move that could result in fresh tariffs - WSJ